Third-party litigation funding is an arrangement in which an outside funder, unconnected to the lawsuit, advances money to a plaintiff or law firm in exchange for a share of any eventual recovery. The financing is typically non-recourse, meaning the funder is repaid only if the case succeeds and receives nothing if it fails, which distinguishes it from an ordinary loan.
This article explains how third-party litigation funding works, the forms it takes, the disclosure and regulation debate surrounding it and its practical effects on litigation. As the practice has grown, it has drawn scrutiny from courts, legislatures and commentators, making a clear, neutral understanding of the mechanics essential.
Third-party litigation funding means that a party with no other stake in a lawsuit provides capital to pursue it and is repaid from the proceeds if the claim prevails. The funder is a stranger to the underlying dispute — not the plaintiff, the defendant or counsel — and its return is contingent on the outcome. Because repayment depends on success, the arrangement transfers much of the financial risk of litigation from the litigant to the funder.
The concept is often traced to the old doctrines of champerty and maintenance, which historically barred outsiders from financing another’s lawsuit. Most U.S. jurisdictions have relaxed or abandoned those prohibitions, allowing funding to develop into an established industry. The funding is structured as an investment in a claim rather than as a debt, which is why the non-recourse feature is central to how it operates and how it is treated legally.
Litigation funding comes in several forms, distinguished mainly by who receives the money and how the return is structured. Consumer funding advances relatively small sums directly to individual plaintiffs, often to cover living or medical expenses while a personal injury case proceeds toward a settlement or structured settlement. Commercial funding provides much larger capital to businesses or law firms for complex litigation and is negotiated as a sophisticated financial transaction. Portfolio funding finances a bundle of cases at once, spreading the funder’s risk across a group of claims.
Each type serves a different need. Consumer funding helps an injured plaintiff avoid settling early out of financial desperation. Commercial and portfolio funding let firms and companies pursue meritorious but expensive claims without bearing the full cost up front. The return may be a multiple of the amount advanced, a percentage of the recovery or a negotiated combination, depending on the deal.
Disclosure and regulation of third-party litigation funding vary widely and remain actively contested. There is no uniform national rule; some jurisdictions require parties to disclose the existence of a funding agreement in discovery, others require it only in specific case types, and many impose no disclosure obligation at all. Consumer funding is more commonly regulated at the state level, sometimes under laws addressing interest rates or requiring specific contract terms, while commercial funding is more lightly regulated.
The central debates concern transparency and influence. Proponents argue that funding expands access to justice, letting under-resourced plaintiffs pursue valid claims against well-funded opponents. Critics contend that undisclosed funders may influence litigation decisions and that opponents are entitled to know who is financing the case. Because the rules differ so sharply by jurisdiction and continue to evolve, counsel should confirm the applicable disclosure and licensing requirements before entering or relying on a funding arrangement.
Litigation funding affects a personal injury case mainly by changing the plaintiff’s financial staying power and, in turn, the settlement dynamic. A plaintiff who can cover living expenses while the case proceeds is less likely to accept an inadequate early offer out of necessity, which can shift negotiating leverage. Because non-recourse funding is not repaid if the case loses, it also does not create ordinary debt for the plaintiff, though the cost of the funding reduces the net recovery.
There are trade-offs and cautions. The funder’s return can consume a significant portion of the recovery, so counsel must ensure the plaintiff understands the true net outcome. Funding also intersects with the debate over large awards and so-called nuclear verdicts, since critics argue outside capital can fuel aggressive litigation. Ethical rules on fee-sharing and professional independence require that the lawyer, not the funder, continue to control the litigation and honor the duty to the client.
Third-party litigation funding is non-recourse financing in which an outside funder advances money for a lawsuit in exchange for a share of any recovery, repaid only if the case succeeds. It exists in consumer, commercial and portfolio forms, and it sits at the center of an unsettled debate over disclosure, regulation and access to justice. Because the governing rules vary so widely and continue to change, practitioners should confirm the applicable requirements and ethical obligations in their jurisdiction before relying on a funding arrangement.
Third-party litigation funding is an arrangement in which an outside funder with no other stake in the case advances money to a plaintiff or law firm in exchange for a share of any recovery. The financing is typically non-recourse, so the funder is repaid only if the case succeeds. It exists to shift the financial risk of litigation from the litigant to the funder.
No, not in the ordinary sense. A traditional loan must be repaid regardless of outcome, while non-recourse litigation funding is repaid only if the case produces a recovery. If the case fails, the funder generally receives nothing. That contingent, outcome-based structure is what distinguishes funding from conventional debt, though some consumer funding is regulated under laws that treat it similarly to lending.
It depends on the jurisdiction and the type of case. Some courts and rules require disclosure of a funding agreement’s existence, others require it only in particular contexts such as certain federal or multidistrict proceedings, and many impose no disclosure duty at all. Because the requirements vary and are evolving, counsel should check the applicable local rule.
Yes, in most U.S. jurisdictions, though the details are regulated differently from place to place. The old doctrines of champerty and maintenance that once barred outside financing have been relaxed or abandoned in most states. Consumer funding in particular may be subject to state licensing or contract-disclosure requirements, so the legality turns on complying with the applicable rules.
Third-party litigation funding is an arrangement in which an outside funder, unconnected to the lawsuit, advances money to a plaintiff or law firm in exchange.
A Rule 30(b)(6) deposition is a deposition of an organization, in which the noticing party lists the topics for examination and the organization must designate.
The work product doctrine shields documents and tangible things prepared by or for a party in anticipation of litigation from discovery by the opposing side..
Discover Next
Learn from experts in personal injury about key cases, the business of law, and more insights that shape the future of trial law.